Belgian biopharma company UCB has tapped customer engagement company Verint Systems to create an app for patients with Parkinson's disease. The app is called PD Coach and includes an AI assistant named April which can communicate with users either by text or speech.
At launch, the app will support journaling and symptoms tracking. April is programmed with a wealth of Parkinson's-specific information, and is designed to be able to communicate with Parkinson's patients through speech and dexterity challenges.
"Our PD Coach, April, offers a vital support system to people living with and caring for those with Parkinson’s disease, leveraging AI technology to provide ongoing, personalized support and access to the resources they need,” Mike Davis, head of UCB’s US Neurology Patient Value Unit, said in a statement. “We designed the PD Coach to address specific challenges that Parkinson’s patients and their caregivers may face — including its unique ability to learn and adjust to language and vocabulary for patients with dexterity and speech issues. With insights from patients on the challenges they face with disease management, April was created as more than a resource to offer information. April is designed to build a relationship with the patient and help deliver what patients value when it comes to their care.”
Why it matters
While pharma companies employ digital health in a variety of ways, including clinical trials, medication adherence plays and digital therapeutics, one of the most basic is companion and wraparound apps for patients. Oftentimes these apps have nothing to do with a particular drug offering, like Pfizer's LivingWith app for cancer patients and Quitter's Circle app for smokers, or Novartis's recently launched Galaxies of Hope app.
"This AI and automation-powered technology creates a new avenue for patients to turn to for help and guidance that has the convenience of an app,” Michael Southworth, general manager of intelligent self-service at Verint, said in a statement. “AI and intelligent assistant technology has the ability to transform healthcare and access for patients. With April, we’ve built a resource that can truly meet patients where they are and allow them to take greater control of their health.”
What's the trend
Parkinson's Disease has been the focus of a number of digital health projects. Apple has been particularly interested in the disease and it was the focus of Sage Bionetwork's mPower app, one of the first studies to be conducted on ResearchKit. The tap tests developed for mPower have also been incorporated into Apple's CareKit framework and can be used to track the progress of the disease.
In 2014, UCB itself embarked on a major partnership with Cambridge-based MC10, which makes paper-thin adhesive health sensors, to study Parkinson's disease using the latter company's technology.
Focus on Artificial Intelligence
In November, we take a deep dive into AI and machine learning.